- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04406675
Social Cognition in Patients With Amyotrophic Lateral Sclerosis (COSISLA)
Amyotrophic Lateral Sclerosis, also known as Charcot disease, is a neurodegenerative disease evidenced by gradual paralysis of the muscles involved in voluntary motor function. The clinical hallmark of Amyotrophic Lateral Sclerosis is the combination of upper and lower motor neuron signs and symptoms. The most recent studies suggest that up to 50% of Amyotrophic Lateral Sclerosis patients demonstrate mild to moderate cognitive disturbance. Impaired social cognition, including a deficit in the recognition of facial emotions and the identification of vocal prosody, is recognized as a part of the cognitive phenotype of Amyotrophic Lateral Sclerosis, with crucial implications for patients' and caregivers' training. However, studies remain scarce and the data acquired must be supported. The evolution of these manifestations during the disease is still poorly understood.
In this study the investigators aim to assess the social cognition capacities of patients with Amyotrophic Lateral Sclerosis compared to healthy matched control subjects.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Cassereau Julien
- Phone Number: 0241355615
- Email: jucassereau@chu-angers.fr
Study Contact Backup
- Name: Muller Jeanne
- Email: jeanne.muller@chu-angers.fr
Study Locations
-
-
-
Angers, France, 49933
- Recruiting
- CHU Angers
-
Contact:
- Muller Jeanne
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Patient Amyotrophic Lateral Sclerosis :
- Education of at least 7 years
- Native language: French
- Patients Amyotrophic Lateral Sclerosis
- Signature of informed consent to participate in the study
- Accompanied patient
Control subject :
- People without any pathology
- Education of at least 7 years
- Native language: French
- Signature of informed consent to participate in the study
Exclusion Criteria:
Patient Amyotrophic Lateral Sclerosis and control subject :
- Simultaneous participation in another interventional protocol with experimental treatment
- Inability to perform cognitive study tests
- Pregnant, lactating or parturient women
- Persons deprived of their liberty by administrative or judicial decision
- Persons under psychiatric care under duress
- Persons subject to legal protection measures
- Persons out of state to express their consent
- People not affiliated or not beneficiaries of a social security scheme
- History likely to disturb cognition
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Control subjects
|
neuropsychological test
|
Other: Patients Amyotrophic Lateral Sclerosis
|
neuropsychological test
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluate the social cognition capacities
Time Frame: One day
|
Evaluate the social cognition capacities of patients with Amyotrophic Lateral Sclerosis compared to control subjects using dynamic social cognition tests : Movie for the Assessment of Social Cognition.
The maximum score is 48 points.
The higher the score for correct answers, the better the performance.
|
One day
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-A01213-36
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Social Cognition
-
University Hospital, Basel, SwitzerlandCompleted
-
IRCCS San RaffaeleCompleted
-
University Medicine GreifswaldCompleted
-
University of Maryland, BaltimoreUniversity of Maryland, College ParkCompleted
-
University Hospital, Basel, SwitzerlandCompleted
-
RWTH Aachen UniversityUnknownThe Impact of Oxytocin on Social CognitionGermany
-
Centre Hospitalier Universitaire, AmiensRecruitingFunctional Magnetic Resonance Imaging | ASD | Social Cognition | Eye Tracking | Joint AttentionFrance
-
University of Maryland, BaltimoreNational Institute on Drug Abuse (NIDA)CompletedSocial Anxiety | Social Cognition | Emotional IntelligenceUnited States
-
Humboldt-Universität zu BerlinComisión Nacional de Investigación Científica y TecnológicaUnknownStress, Psychological | Emotional Stress | Mindfulness | Social CognitionGermany
-
University of La LagunaUniversity of Santiago de CompostelaCompletedSocial CognitionSpain
Clinical Trials on neuropsychological test
-
Umeå UniversityCompletedNormal Pressure HydrocephalusSweden
-
Centre Hospitalier Universitaire de BesanconUnknown
-
The Affiliated Hospital of Inner Mongolia Medical...Recruiting
-
Turku University HospitalEuropean Commission; Ocuspecto OyUnknownGlaucoma | Healthy | Mild Cognitive Impairment | Glaucoma and Mild Cognitive ImpairmentFinland
-
University Hospital, AngersCompletedHuntington's DiseaseFrance
-
ImPACT Applications, Inc.TerminatedBrain Concussion | Mild Cognitive ImpairmentUnited States
-
Centre Francois BaclesseUCOG (Unite de coordination en Onco-Gériatrie)Completed
-
National Institute for Medical Rehabilitation,...Semmelweis UniversityRecruiting
-
IRCCS Policlinico S. DonatoCompletedCongenital Heart Disease | Aging, Premature | White Matter HyperintensitiesItaly
-
University Hospital, BordeauxCompletedMultiple System AtrophyFrance